Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Kidney Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Not applicableLooking for participantsNCT06718894
What this trial is testing

Multitarget Strategy for Primary Podocytopathies

Who this might be right for
Nephrotic Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT04870333
What this trial is testing

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Who this might be right for
Covid19
Cambridge University Hospitals NHS Foundation Trust 2,240
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Post-approval studies (Phase 4)Study completedNCT00374647
What this trial is testing

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

Who this might be right for
Primary Renal Allograft
University of Cincinnati 17
Post-approval studies (Phase 4)Not Yet RecruitingNCT07706166
What this trial is testing

Letermovir for R+ Study

Who this might be right for
Kidney TransplantLiver Transplant
University of Wisconsin, Madison 146
Post-approval studies (Phase 4)Study completedNCT00121810
What this trial is testing

Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 305
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Large-scale testing (Phase 3)Study completedNCT00189839
What this trial is testing

Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 699
Post-approval studies (Phase 4)Ended earlyNCT02523768
What this trial is testing

Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

Who this might be right for
GlomerulonephritisIgAN
Centre Hospitalier Universitaire de Saint Etienne 117
Very early researchEnrolling By InvitationNCT05950724
What this trial is testing

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

Who this might be right for
Lung Transplant; Complications
Northwestern University 20
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Post-approval studies (Phase 4)UnknownNCT00252655
What this trial is testing

Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Wayne State University 40
Post-approval studies (Phase 4)Study completedNCT00681343
What this trial is testing

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

Who this might be right for
Living-Donor Kidney Transplant
University of Miami 38
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Large-scale testing (Phase 3)Ended earlyNCT00137345
What this trial is testing

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 500
Next Page